Home / Brand archive
11 reported ongoing
12 records in this archive. Latest source date Mar 13, 2026. 1 published notices do not supply a closure status.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Crystallization; identified as Buprenorphine free base
Class IIReported ongoing
Distribution: USA Nationwide
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIReported ongoing
Distribution: Nationwide within the United States
Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
Class IReported ongoing
Distribution: USA nationwide.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IReported ongoing
Distribution: Nationwide in the USA
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IReported ongoing
Distribution: Nationwide in the USA
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IReported ongoing
Distribution: Nationwide in the USA
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IReported ongoing
Distribution: Nationwide in the USA
Mislabeled with the incorrect strength on the carton
Not suppliedPublished notice; closure not supplied
Distribution: The product lot was distributed through wholesale distributors to retail pharmacies nationwide. Endo is providing written notification to wholesale accounts and retailers that h...
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 12 records, including 11 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.